Compare GSK plc (GSK) vs SMX Security Matters plc (SMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs SMX Security Matters plc — how do they compare? GSK plc trades at $52.64 (market cap $101.34B), while SMX Security Matters plc trades at $20 (market cap $19.00M). The key difference: GSK plc is far larger — about 5333.7× SMX Security Matters plc's market cap, and GSK plc pays a 3.49% dividend while SMX Security Matters plc pays none. Which is the better fit depends on your goals.
| GSK | SMX | |
|---|---|---|
Market Cap | $101.34B | $19.00M |
Sector | Health | Technology |
52-Week High | $61.18 | $295.56K |
52-Week Low | $36.20 | $12.87 |
Enterprise Value | $121.95B | $15.98M |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
SMX trades at $20.08, up 14.74% over 24 hours, following two reverse stock splits in May and June 2026. Technical indicators are neutral to bearish, with support at $15 and resistance at $16. The company is focusing on its Circularity-as-a-Service platform for plastics traceability, capitalizing on regulatory shifts favoring recycled materials. However, profitability remains a concern with negative ROE and ROA.
The outlook hinges on SMX's ability to monetize its technology amid growing demand for verified recycled plastics. Key risks include execution challenges and persistent unprofitability. Analyst sentiment is mixed, with the stock's recent surge needing fundamental support to sustain momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
